Re: ERT/HRT- personal prescribing trend

From: Dib Abdalla Chacur (dibchacur@uol.com.br)
Thu Oct 24 10:50:07 2002


I would like to know if the reference of the article is right Regards Dib

--
DIB ABDALLA CHACUR
Gynecology - Mastology
Teacher of Gynecology of CAMPOS SCHOLL OF MEDICINE
Adress: Rua Barão de Miracema, 237
Campos dos Goytacazes , RJ, Brazil
dibchacur@uol.com.br
28.030-360

>----- Original Message ----- From: "Joanne Bulley, MD" <islesannie@yahoo.com> To: "Multiple recipients of list OB-GYN-L" <ob-gyn-l@mail.medispecialty.com> Sent: Sunday, October 20, 2002 2:14 PM Subject: Re: ERT/HRT- personal prescribing trend

>Shairer et al. Menopausal Estrogen and Estrogen-Progestin Replacement Therapy and Breast Cancer Risk. JAMA 2000; 283:485-491

> -- > Joanne Bulley, MD > Keene, NH, USA >





use when must restrict search to only the ob-gyn-l forum...
Enter search keywords:
Returns per screen: Require all keywords:

Return to  OB-GYN-L Mail a New Message to the Forum: ob-gyn-l@obgyn.net
Forum Administrator: geffrey.klein@obgyn.net
Report Technical Problems: webmaster@obgyn.net
Last Updated: Mon Nov 2 04:52:29 2009

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.